Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
Curtiss-Wright delivered strong first-quarter 2026 growth with higher sales, earnings, and margins. Total net sales rose to $913.7 million from $805.6 million, led by double‑digit gains in the Naval & Power and Aerospace & Industrial segments. Net earnings increased to $128.2 million from $101.3 million, and diluted EPS grew to $3.46 from $2.68 as operating margin expanded to 17.5%.
Defense and commercial markets both advanced, with aerospace and defense sales reaching $641.4 million and commercial markets $272.3 million. New orders climbed 16% to about $1.2 billion, supporting a backlog of approximately $4.3 billion, of which 90% is expected to convert to revenue over 36 months.
Cash from operations was a modest use of $5.7 million but improved sharply from a $38.8 million use a year earlier, while cash and equivalents stood at $343.4 million. Debt remained stable at about $957.5 million, and the company repurchased roughly 22,000 shares for $14 million under its ongoing buyback programs and Rule 10b5‑1 trading plans.
CURTISS WRIGHT CORP director Jeffrey J. Lyash filed an initial Form 3 reporting his status as a director of the company. The filing shows no reported transactions, no share purchases or sales, and no derivative positions or holdings disclosed in this submission.
Curtiss-Wright Corporation reported strong first quarter 2026 results and raised its full-year outlook. Q1 2026 sales reached $914 million, up 13% from $806 million a year earlier, with operating income of $160 million, up 23%, and an operating margin of 17.5%.
Adjusted operating income was $160 million, up 20%, and adjusted operating margin rose 100 basis points to 17.6%. Adjusted diluted EPS increased 23% to $3.48. Orders were about $1.2 billion, up 16%, producing a 1.3x book-to-bill, and backlog was roughly $4.3 billion, up 5% from December 31, 2025.
The company raised its 2026 adjusted guidance, now targeting total sales of $3.74–$3.80 billion (7–8% growth), operating income growth of 9–12%, an operating margin of 19.0–19.2%, diluted EPS of $14.90–$15.30 (13–16% growth), and free cash flow of $580–$600 million with more than 105% free cash flow conversion.
Curtiss-Wright Corp ownership disclosure: Vanguard Capital Management reports beneficial ownership of 1,923,453 shares of Curtiss-Wright common stock, representing 5.21% of the class. The filing shows sole dispositive power over 1,923,453 shares and sole voting power over 270,672 shares as reported.
The filing is a Schedule 13G signed 04/29/2026 and states ownership counts and the CUSIP 231561101. Vanguard’s disclosure notes holdings include securities held for Vanguard funds and managed accounts and lists affiliated voting/dispositive relationships in accordance with SEC Release No. 34-39538.
The Vanguard Group filed Amendment No. 12 to a Schedule 13G/A reporting 0% ownership—0 shares—of Curtiss‑Wright Corp. The filing states that, January 12, 2026, The Vanguard Group, Inc. completed an internal realignment and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The amendment lists the filer’s address and confirms no sole or shared voting or dispositive power over Curtiss‑Wright common stock. The signature block is dated 03/26/2026.
Curtiss-Wright Corporation is soliciting proxies for its 2026 annual meeting on May 7, 2026 in Davidson, North Carolina. Stockholders will vote on electing nine directors, ratifying Deloitte & Touche LLP as independent auditor for 2026, and approving on an advisory basis executive compensation.
The Board highlights strong governance practices, with 8 of 9 director nominees independent and all key committees fully independent. It reports very strong 2025 performance, including 11.6% adjusted organic sales growth, 18.5% adjusted operating margin, working capital at 19.2% of sales, and three-year total shareholder return in the 93rd percentile versus peers.
The proxy emphasizes a pay-for-performance compensation philosophy, robust clawback and stock ownership policies, and a comprehensive ESG and corporate social responsibility program, including cybersecurity, ethics, responsible sourcing, and community initiatives. Stockholders of record at the close of business on March 13, 2026, when 36,907,171 common shares were outstanding, are entitled to vote.
Curtiss-Wright Corporation Senior VP & Corporate Controller Gary A. Ogilby reported an open-market sale of 252 shares of Common Stock on March 18, 2026 at an average price of $689.14 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. Following this sale, Ogilby directly holds 2,571 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation Executive VP and CFO K. Christopher Farkas reported an open-market sale of 1,265 shares of common stock at an average price of $689.69 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan maintained by his financial advisor. Following this transaction, Farkas directly holds 4,253 shares of Curtiss-Wright common stock. The shares were sold in multiple trades at prices ranging from $681.18 to $699.31 per share.
CW filed a Form 144 reporting a proposed sale of 1,265 shares of Common Stock through UBS Financial Services (NYSE) tied to an RSU vesting on 03/16/2026.
The filing names K. Christopher Farkas and lists prior dispositions in the past three months: 3,105 shares sold on 02/18/2026 for $2,156,439.58 and 2,665 shares sold on 02/04/2026 for $1,669,034.61.